We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Updated: 1/5/2016
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Updated: 1/5/2016
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated: 1/5/2016
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Updated: 1/5/2016
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Updated: 1/5/2016
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated: 1/5/2016
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Updated: 1/5/2016
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Antifolate Effectiveness in Arthritis
Updated: 1/5/2016
Mechanisms of Antifolate Efficacy in Arthritis
Status: Enrolling
Updated: 1/5/2016
Antifolate Effectiveness in Arthritis
Updated: 1/5/2016
Mechanisms of Antifolate Efficacy in Arthritis
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Improving Vocational Outcomes in Arthritis
Updated: 1/5/2016
Improving Vocational Outcomes in Arthritis
Status: Enrolling
Updated: 1/5/2016
Improving Vocational Outcomes in Arthritis
Updated: 1/5/2016
Improving Vocational Outcomes in Arthritis
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Registry for African Americans With Early Rheumatoid Arthritis
Updated: 1/5/2016
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
A Study in Moderate to Severe Rheumatoid Arthritis
Updated: 1/6/2016
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials